Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | CASP3 | P42574 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1337301 | 0.90 | ALDH1A1 (0.38) | MEN1ALDH1A1KMT2ACASP3LMNA | |
| SCHEMBL1337231 | 0.87 | MEN1 (0.42) | MEN1ALDH1A1KMT2ALMNAHTT | |
| SCHEMBL6031443 | 0.86 | MEN1 (0.37) | MEN1ALDH1A1KMT2ALMNAHTT | |
| SCHEMBL1335829 | 0.86 | MEN1 (0.37) | MEN1ALDH1A1KMT2ALMNAHTT | |
| SCHEMBL5814580 | 0.78 | TNIK (0.33) | — | |
| SCHEMBL4492303 | 0.78 | LMNA (0.47) | MEN1ALDH1A1KMT2ALMNAHTT | |
| SCHEMBL4473406 | 0.78 | ALDH1A1 (0.42) | MEN1ALDH1A1KMT2ALMNAHTT | |
| SCHEMBL1336916 | 0.78 | MEN1 (0.42) | MEN1ALDH1A1KMT2ALMNAHTT | |
| SCHEMBL4479139 | 0.75 | AKR1B1 (0.35) | MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL10232272 | 0.74 | MEN1 (0.40) | MEN1ALDH1A1KMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1725556-A1 | HIV INTEGRASE INHIBITORS | Merck & Co., Inc. (US) | 2006-11-29 | — | — | EP | disclosed |
| WO-2005087768-A1 | HIV INTEGRASE INHIBITORS | MERCK & CO., INC. (US) | 2005-09-22 | — | — | WO | disclosed |